Article Text

Download PDFPDF
Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure
  1. T Goto1,
  2. H Takase1,
  3. T Toriyama1,
  4. T Sugiura1,
  5. K Sato2,
  6. R Ueda3,
  7. Y Dohi3
  1. 1Department of Internal Medicine, Enshu General Hospital, Hamamatsu, Japan
  2. 2Department of Internal Medicine, Johoku Hospital, Nagoya, Japan
  3. 3Internal Medicine and Molecular Science, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan
  1. Correspondence to:
    Dr Y Dohi
    Internal Medicine and Molecular Science, Graduate School of Medical Sciences, Nagoya City University, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan; ydohimed.nagoya-cu.ac.jp

Abstract

Objective: To test the hypothesis that myocardium specific proteins may be useful markers for evaluating the severity of congestive heart failure.

Methods: Serum concentrations of myosin light chain I (MLC-I), heart fatty acid binding protein (H-FABP), creatine kinase isoenzyme MB (CK-MB), and troponin T (TnT) and plasma concentrations of brain natriuretic peptide (BNP) were determined in 48 patients with acute deterioration of congestive heart failure, both before and after effective treatment.

Results: Before treatment, MLC-I (mean (SEM) 3.2 (2.2) μg/l), H-FABP (9.0 (3.5) μg/l), TnT (30 (21) ng/l), and BNP (761 (303) ng/l) were higher than the normal reference range, and concentrations of CK-MB (5.4 (2.9) μg/l) were near normal. Treatment of congestive heart failure with conventional medication significantly decreased the concentrations of MLC-I (1.2 (0.3) μg/l, p < 0.0001), H-FABP (6.0 (2.0) μg/l, p < 0.0001), CK-MB (2.9 (1.5) μg/l, p < 0.0001), TnT (9 (1) ng/l, p < 0.001), and BNP (156 (118) ng/l, p < 0.0001). The decreases in H-FABP and CK-MB concentrations after treatment correlated with the decrease in BNP concentrations (p < 0.05). The absolute concentrations of MLC-I, H-FABP, CK-MB, and TnT correlated positively with those of BNP (p < 0.01).

Conclusions: These findings suggest that MLC-I, H-FABP, CK-MB, and TnT may be used as reliable markers for the evaluation of the severity of congestive heart failure.

  • brain natriuretic peptide
  • creatine kinase isoenzyme MB
  • heart fatty acid binding protein
  • myosin light chain I
  • troponin T
  • BNP, brain natriuretic peptide
  • CHF, congestive heart failure
  • CK-MB, creatine kinase isoenzyme MB
  • H-FABP, heart fatty acid binding protein
  • MLC-I, myosin light chain I
  • NYHA, New York Heart Association
  • TnT, troponin T

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

Linked Articles

  • Miscellanea
    BMJ Publishing Group Ltd and British Cardiovascular Society